These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8266818)

  • 1. Inhibition of tumor necrosis factor-alpha secretion by pentoxifylline in advanced cancer patients with abnormally high blood levels of tumor necrosis factor-alpha.
    Lissoni P; Ardizzoia A; Perego MS; Grassi MG; Arosio M; D'Amico P; Cazzaniga M; Crispino S; Tancini G; Barni S
    J Biol Regul Homeost Agents; 1993; 7(2):73-5. PubMed ID: 8266818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin.
    Lissoni P; Barni S; Tancini G; Brivio F; Tisi E; Zubelewicz B; Braczkowski R
    J Biol Regul Homeost Agents; 1994; 8(4):126-9. PubMed ID: 7660855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
    Selim K; Hüseyin C; Ibrahim KH; Hasan BU; Kazim U; Hüseyin K
    Med J Malaysia; 2004 Aug; 59(3):391-4. PubMed ID: 15727386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of pentoxifylline induced modulation of TNF alpha and interleukin-6 secretion in healthy and septic patients by the use of an ex-vivo model on whole blood.
    Bienvenu J; Coulon L; Barbier Y; Barbier M; Doche C; Lepape A; Guenounou M
    Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S65-7. PubMed ID: 1340532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.
    Ardizzoia A; Lissoni P; Brivio F; Tisi E; Perego MS; Grassi MG; Pittalis S; Crispino S; Barni S; Tancini G
    J Biol Regul Homeost Agents; 1992; 6(3):103-7. PubMed ID: 1492596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II study of pentoxifylline with zidovudine on HIV-1 growth in AIDS patients.
    Luke DR; McCreedy BJ; Sarnoski TP; Bookout JB; Johnston AM; Lell JE; Wiggan EB; Bell N; Limjuco RA; Guthrie KI
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):343-50. PubMed ID: 8370633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
    de Moura FJ; Leal PP; de Souza Furtado R; Muniz-Junqueira MI; Veiga JP
    Toxicology; 2008 Jan; 243(1-2):66-74. PubMed ID: 18022309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of oral pentoxifylline on the cytokine release syndrome during inductive OKT3.
    DeVault GA; Kohan DE; Nelson EW; Holman JM
    Transplantation; 1994 Feb; 57(4):532-40. PubMed ID: 8116037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study.
    el-Darouti M; Marzouk S; Abdel Hay R; el-Tawdy A; Fawzy M; Leheta T; Gammaz H; Al Gendy N
    Br J Dermatol; 2009 Aug; 161(2):313-9. PubMed ID: 19466963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients.
    Zubelewicz B; Romanowski W; Braczkowska B; Lissoni P; Braczkowski R
    J Exp Clin Cancer Res; 1998 Dec; 17(4):449-52. PubMed ID: 10089067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties.
    Fantin M; Quintieri L; Kúsz E; Kis E; Glavinas H; Floreani M; Padrini R; Duda E; Vizler C
    Eur J Pharmacol; 2006 Mar; 535(1-3):301-9. PubMed ID: 16545799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
    Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
    Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM
    Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins.
    Arias-Díaz J; Vara E; García C; Balibrea JL
    J Clin Invest; 1994 Jul; 94(1):244-50. PubMed ID: 8040266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms.
    Braczkowski R; Zubelewicz B; Romanowski W; Lissoni P; Brivio F
    J Exp Clin Cancer Res; 1998 Sep; 17(3):349-54. PubMed ID: 9894774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue.
    Hassan MI; Kassim SK; Saeda L; Laban M; Khalifa A
    Anticancer Res; 1999; 19(6C):5657-62. PubMed ID: 10697636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy].
    Balázs C; Kiss E; Vámos A; Molnár I; Farid NR
    Orv Hetil; 1997 Nov; 138(45):2869-74. PubMed ID: 9432636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
    Satapathy SK; Garg S; Chauhan R; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    Am J Gastroenterol; 2004 Oct; 99(10):1946-52. PubMed ID: 15447754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.